GTCM
KYNB

Gyon Technologies Capital Management’s Kyntra Bio KYNB Stock Holding History

Gyon Technologies Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,025
Closed -$333K – 525
2022
Q3 		$333K Buy
+1,025
New +$330K 0.1% 229

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gyon Technologies Capital Management's KYNB Position: Q4 2022 in Review

Gyon Technologies Capital Management sold out of Kyntra Bio (KYNB) in Q4 2022, closing a stake of 1,025 shares — an estimated $333K sold.

Gyon Technologies Capital Management first reported a position in KYNB in Q3 2022 and held it in 1 quarter. The position peaked at $333K in Q3 2022. 144 funds tracked by Wall St. Rank hold KYNB as of Q4 2022.

  • Gyon Technologies Capital Management reported no remaining Kyntra Bio position as of Q4 2022 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 1,025 Kyntra Bio shares in Q4 2022, an estimated $333K.
  • Gyon Technologies Capital Management first reported a position in Kyntra Bio in Q3 2022 and held it in 1 quarter.
  • Gyon Technologies Capital Management's Kyntra Bio position peaked at $333K in Q3 2022.
  • 144 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.